Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Cancer target chemopreventive drugs

Nuclear factor kappa B (NF-kB) serves as a central regulator of the human immune and inflammatory response, and is a family of inducible transcription factors found virtually ubiquitously in all cells and functions in a variety of human diseases including those related to inflammation, cancer, asthma, atherosclerosis, AIDS, septic shock, and arthritis. Due to its role in a wide variety of diseases, NF-kB has become one of the major targets for drug development. Inhibition of NF-kB activity potentially contributes to cancer chemoprevention [27,28]. [Pg.80]

Trosko JE and Ruch RJ (2002) Gap junctions as targets for cancer chemoprevention and chemotherapy. Current Drug Targets 3 465—482. [Pg.1219]

Klampfer, L. Signal transducers and activators of transcription (STATs) novel targets of chemopreventive and chemotherapeutic drugs. Curr. Cancer Drug Targets 2006, 6, 107-121. [Pg.105]

See other pages where Cancer target chemopreventive drugs is mentioned: [Pg.136]    [Pg.591]    [Pg.155]    [Pg.28]    [Pg.181]    [Pg.210]    [Pg.30]    [Pg.15]    [Pg.327]    [Pg.93]    [Pg.188]    [Pg.137]    [Pg.175]    [Pg.141]    [Pg.155]    [Pg.2191]    [Pg.2225]    [Pg.73]    [Pg.197]    [Pg.72]    [Pg.73]   
See also in sourсe #XX -- [ Pg.30 , Pg.591 ]

See also in sourсe #XX -- [ Pg.591 ]



SEARCH



Cancer chemoprevention

Cancer target

Chemoprevention

Chemopreventive

Drugs targeting

Drugs, chemopreventive

Targeted drugs

© 2024 chempedia.info